RHÖN-KLINIKUM AG starts financial year 2024 with a good first quarter

EQS-News: RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): Quarter
Results/Quarter Results
RHÖN-KLINIKUM AG starts financial year 2024 with a good first quarter

08.05.2024 / 08:59 CET/CEST
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Corporate News

Bad Neustadt a. d. Saale | 8 May 2024


RHÖN-KLINIKUM AG starts financial year 2024 with a good first quarter

RHÖN-KLINIKUM AG, one of the leading healthcare providers in Germany, has
made a solid start to financial year 2024. Both consolidated profit and
EBITDA as well as revenues rose in the first three months.

Revenues increased by 5.9% to EUR382.8 million (Q1 2023: EUR361.5 million). At
EUR25.2 million, EBITDA (earnings before interest, taxes, depreciation and
amortisation) was 12% higher than the previous year (Q1 2023: EUR22.5
million). Taking into account depreciation, amortisation, financing costs
and taxes, EBITDA resulted in a consolidated profit of EUR11.1 million (Q1
2023: EUR6.4 million). From January to March 2024, 234,151 outpatients and
inpatients were treated in the Group's hospitals and medical care centers
(Q1 2023: 228,189).

'RHÖN-KLINIKUM AG considers itself well prepared for the forthcoming
hospital reform with positioning of its hospitals. With our RHÖN Campus
concept, the growing range of outpatient treatment services and the
establishment of new medical services, we are seizing opportunities that we
will implement for the benefit of our patients', says Prof. Dr Tobias
Kaltenbach, Chairman of the Board of Management of RHÖN-KLINIKUM AG.


Outlook for 2024 confirmed

For the coming financial year, RHÖN-KLINIKUM AG expects revenues of EUR1.6
billion euros within a range of +/- 5% upwards and downwards respectively.
For earnings before interest, tax and depreciation and amortisation
(EBITDA), a level of between EUR110 million euros and EUR120 million is
expected.

This outlook reflects the further tightening of regulatory intervention by
the legislator. RHÖN-KLINIKUM AG points out that the outlook is subject to
considerable uncertainties in connection with the numerous global crises
resulting in inflation and price increases and subject to any regulatory
intervention causing the remuneration structure in 2024.


Quarterly Statement - Q1 2024

RHÖN-KLINIKUM AG is one of the leading healthcare providers in Germany. The
hospitals offer excellent medical care with a direct tie-in to universities
and research facilities. Each year some 882,000 patients are treated at our
five sites - RHÖN-KLINIKUM Campus Bad Neustadt, Klinikum Frankfurt (Oder),
Universitätsklinikum Gießen and Universitätsklinikum Marburg (UKGM) as well
as Zentralklinik Bad Berka. The Company employs over 18,200 persons. The
innovative RHÖN Campus approach committed to cross-sector and
future-oriented healthcare delivery in rural areas, the steadfast
continuation of the gradual digital transformation within the Company as
well as the strategic partnership with Asklepios are key elements of our
corporate strategy. RHÖN-KLINIKUM AG is an independent Company operating
under the umbrella of Asklepios Kliniken GmbH & Co. KGaA.
www.rhoen-klinikum-ag.com


Contact:

RHÖN-KLINIKUM AG |Head of Corporate Finance, Treasury, Investor Relations
and Sustainability
Julian Schmitt
T. +49 9771 65-12250 | julian.schmitt@rhoen-klinikum-ag.com


RHÖN-KLINIKUM AG | Schlossplatz 1 | D-97616 Bad Neustadt a. d. Saale


---------------------------------------------------------------------------

08.05.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS
News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---------------------------------------------------------------------------

   Language:       English
   Company:        RHÖN-KLINIKUM Aktiengesellschaft
                   Salzburger Leite 1
                   97616 Bad Neustadt a.d.Saale
                   Germany
   Phone:          +49 (0)9771 - 65-0
   Fax:            +49 (0)9771 - 97 467
   E-mail:         rka@rhoen-klinikum-ag.com
   Internet:       www.rhoen-klinikum-ag.com
   ISIN:           DE0007042301
   WKN:            704230
   Listed:         Regulated Market in Frankfurt (Prime Standard), Munich;
                   Regulated Unofficial Market in Berlin, Dusseldorf,
                   Hamburg, Hanover, Stuttgart, Tradegate Exchange
   EQS News ID:    1898205

End of News EQS News Service
---------------------------------------------------------------------------

1898205 08.05.2024 CET/CEST